← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity

HYPR logoHyperfine, Inc.(HYPR)Earnings, Financials & Key Ratios

HYPR•NASDAQ
$1.68
$158M mkt cap·Price updated May 7, 2026
SectorHealthcareIndustryMedical DevicesSub-IndustryImaging, radiation, and oncology devices
AboutHyperfine, Inc. provides imaging, monitoring, and magnetic resonance imaging products. It offers Swoop Portable MR imaging system to address an unmet need in point-of-care medical imaging through a combination of hardware and software services. The company was incorporated in 2014 and is based in Guilford, Connecticut.Show more
  • Revenue$14M+5.2%
  • EBITDA-$35M+17.4%
  • Net Income-$36M+12.6%
  • EPS (Diluted)-0.43+23.2%
  • Gross Margin49.79%+8.9%
  • EBITDA Margin-257.2%+21.5%
  • Operating Margin-273.43%+18.5%
  • Net Margin-262.29%+17.0%
  • ROE-79.01%-29.5%
  • ROIC-316.35%-2.8%
Technical→

HYPR Key Insights

Hyperfine, Inc. (HYPR) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Momentum leader: RS Rating 92 (top 8%)
  • ✓Strong 5Y sales CAGR of 115.2%

✗Weaknesses

  • ✗Weak Piotroski F-Score: 3/9
  • ✗Negative free cash flow
  • ✗Shares diluted 30.1% in last year
  • ✗Low asset turnover indicates capital-intensive operations

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

HYPR Price & Volume

Hyperfine, Inc. (HYPR) stock price & volume — 10-year historical chart

Loading chart...

HYPR Growth Metrics

Hyperfine, Inc. (HYPR) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years115.18%
3 Years25.79%
TTM5.22%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM12.64%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM21.29%

Return on Capital

10 Years-57.89%
5 Years-57.4%
3 Years-62.86%
Last Year-79.16%

HYPR Recent Earnings

Hyperfine, Inc. (HYPR) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 3/12 qtrs (25%)●Beat Revenue 6/12 qtrs (50%)
Q2 2026Latest
Mar 18, 2026
EPS
$0.08
Est $0.08
+0.0%
Revenue
$5M
Est $5M
+2.7%
Q4 2025
Nov 13, 2025
EPS
$0.11
Est $0.10
-10.0%
Revenue
$3M
Est $5M
-35.2%
Q3 2025
Aug 13, 2025
EPS
$0.12
Est $0.12
+0.0%
Revenue
$3M
Est $3M
-10.1%
Q2 2025
May 13, 2025
EPS
$0.12
Est $0.12
+0.0%
Revenue
$2M
Est $3M
-33.1%
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMar 18, 2026
$0.08vs $0.08+0.0%
$5Mvs $5M+2.7%
Q4 2025Nov 13, 2025
$0.11vs $0.10-10.0%
$3Mvs $5M-35.2%
Q3 2025Aug 13, 2025
$0.12vs $0.12+0.0%
$3Mvs $3M-10.1%
Q2 2025May 13, 2025
$0.12vs $0.12+0.0%
$2Mvs $3M-33.1%
Based on last 12 quarters of dataView full earnings history →

HYPR Peer Comparison

Hyperfine, Inc. (HYPR) competitors in Imaging, radiation, and oncology devices — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
PRCT logoPRCTPROCEPT BioRobotics CorporationDirect Competitor1.45B25.44-14.7937.22%-31.82%-27.7%0.14
NVCR logoNVCRNovoCure LimitedDirect Competitor1.92B16.83-13.808.28%-25.66%-50.82%0.85
INVA logoINVAInnoviva, Inc.Direct Competitor1.93B22.806.9118.52%118.91%46.47%0.23
AEYE logoAEYEAudioEye, Inc.Direct Competitor100.43M8.09-32.3614.52%-7.63%-47.8%0.15
GEHC logoGEHCGE HealthCare Technologies Inc.Product Competitor27.9B61.3413.484.84%7.54%14.45%0.94
SYK logoSYKStryker CorporationProduct Competitor112.69B294.2535.0311.16%12.92%15.04%0.66
IRTC logoIRTCiRhythm Technologies, Inc.Product Competitor4.1B124.87-89.8326.24%-3.53%-20.6%4.79
INSP logoINSPInspire Medical Systems, Inc.Product Competitor1.31B45.579.3213.6%14.33%17.98%0.04

Compare HYPR vs Peers

Hyperfine, Inc. (HYPR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs PRCT

Most directly comparable listed peer for HYPR.

Scale Benchmark

vs NVDA

Larger-name benchmark to compare HYPR against a more recognizable public peer.

Peer Set

Compare Top 5

vs PRCT, NVCR, INVA, AEYE

HYPR Income Statement

Hyperfine, Inc. (HYPR) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
Line itemDec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25
Sales/Revenue0294K1.5M6.81M11.03M12.89M13.56M
Revenue Growth %--408.84%355.48%61.9%16.84%5.22%
Cost of Goods Sold0771K2.66M5.91M6.28M7M6.81M
COGS % of Revenue-262.24%178.01%86.69%56.88%54.3%50.21%
Gross Profit
0▲ 0%
-477K▲ 0%
-1.17M▼ 144.7%
907K▲ 177.7%
4.76M▲ 424.5%
5.89M▲ 23.8%
6.75M▲ 14.6%
Gross Margin %--162.24%-78.01%13.31%43.12%45.7%49.79%
Gross Profit Growth %---144.65%177.72%424.48%23.84%14.63%
Operating Expenses19.97M23.01M63.7M74.78M52.87M49.12M43.84M
OpEx % of Revenue-7827.89%4258.09%1097.46%479.26%381.03%323.22%
Selling, General & Admin6.58M8.42M37.86M46.63M30.38M26.62M26.39M
SG&A % of Revenue-2864.29%2530.68%684.25%275.37%206.49%194.55%
Research & Development13.39M14.59M25.84M28.16M22.49M22.5M17.45M
R&D % of Revenue-4963.61%1727.41%413.21%203.89%174.55%128.67%
Other Operating Expenses0000000
Operating Income
-19.97M▲ 0%
-23.49M▼ 17.6%
-64.87M▼ 176.1%
-73.87M▼ 13.9%
-48.12M▲ 34.9%
-43.22M▲ 10.2%
-37.09M▲ 14.2%
Operating Margin %--7990.14%-4336.1%-1084.15%-436.14%-335.33%-273.43%
Operating Income Growth %--17.64%-176.14%-13.88%34.87%10.17%14.2%
EBITDA-19.83M-23.2M-64.14M-72.86M-47.06M-42.22M-34.88M
EBITDA Margin %--7891.84%-4287.57%-1069.25%-426.59%-327.5%-257.2%
EBITDA Growth %--17.02%-176.45%-13.59%35.41%10.3%17.37%
D&A (Non-Cash Add-back)141K289K726K1.01M1.05M1.01M2.2M
EBIT-19.97M-23.49M-64.87M-73.87M-48.12M-43.22M-37.09M
Net Interest Income630K70K18K761K3.84M2.49M1.02M
Interest Income630K70K18K761K3.84M2.49M1.02M
Interest Expense0000000
Other Income/Expense553K64K17K710K3.88M2.5M1.51M
Pretax Income
-19.41M▲ 0%
-23.43M▼ 20.7%
-64.85M▼ 176.8%
-73.16M▼ 12.8%
-44.24M▲ 39.5%
-40.72M▲ 8.0%
-35.57M▲ 12.6%
Pretax Margin %--7968.37%-4334.96%-1073.73%-401%-315.9%-262.29%
Income Tax0000000
Effective Tax Rate %0%0%0%0%0%0%0%
Net Income
-18.79M▲ 0%
-23.36M▼ 24.3%
-64.83M▼ 177.6%
-73.16M▼ 12.8%
-44.24M▲ 39.5%
-40.72M▲ 8.0%
-35.57M▲ 12.6%
Net Margin %--7944.56%-4333.76%-1073.73%-401%-315.9%-262.29%
Net Income Growth %--24.34%-177.57%-12.85%39.54%7.95%12.64%
Net Income (Continuing)-19.41M-23.43M-64.85M-73.16M-44.24M-40.72M-35.57M
Discontinued Operations0000000
Minority Interest0000000
EPS (Diluted)
-4.06▲ 0%
-0.93▲ 77.1%
-0.92▲ 1.1%
-1.04▼ 13.0%
-0.62▲ 40.4%
-0.56▲ 9.7%
-0.43▲ 23.2%
EPS Growth %-77.09%1.08%-13.04%40.38%9.68%23.21%
EPS (Basic)-4.06-0.93-0.92-1.04-0.62-0.56-0.43
Diluted Shares Outstanding4.62M25.2M70.33M70.45M71.32M72.41M94.2M
Basic Shares Outstanding4.62M25.2M70.33M70.45M71.32M72.41M94.2M
Dividend Payout Ratio-------

HYPR Balance Sheet

Hyperfine, Inc. (HYPR) balance sheet — assets, liabilities & shareholders' equity

Line itemDec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25
Total Current Assets27.96M68.33M197.49M128.66M88.91M53.71M50.91M
Cash & Short-Term Investments26.44M62.68M188.5M118.24M75.18M37.65M35.09M
Cash Only26.44M62.68M188.5M118.24M75.18M37.65M35.09M
Short-Term Investments0000000
Accounts Receivable0174K644K3.13M4.13M8.3M6.52M
Days Sales Outstanding-216.02157.13167.66136.68235.17175.52
Inventory01.72M4.31M4.62M6.58M5.83M7.09M
Days Inventory Outstanding-813.32590.74285.6382.86304.14380.01
Other Current Assets683K3.54M2.87M2.67M3.01M1.93M2.21M
Total Non-Current Assets2.61M3.19M4.99M5.39M5.29M5.19M4.35M
Property, Plant & Equipment489K1.9M3.75M3.25M3M3.12M2.55M
Fixed Asset Turnover-0.15x0.40x2.10x3.68x4.13x5.32x
Goodwill0000000
Intangible Assets0000000
Long-Term Investments000744K0825K734K
Other Non-Current Assets2.12M1.29M1.24M1.4M2.29M1.24M1.07M
Total Assets
30.57M▲ 0%
71.53M▲ 134.0%
202.47M▲ 183.1%
134.05M▼ 33.8%
94.2M▼ 29.7%
58.9M▼ 37.5%
55.26M▼ 6.2%
Asset Turnover-0.00x0.01x0.05x0.12x0.22x0.25x
Asset Growth %-133.97%183.08%-33.79%-29.73%-37.47%-6.18%
Total Current Liabilities1.79M4.12M15.74M8.8M8.77M8.73M11.73M
Accounts Payable1.19M948K2.25M678K1.21M1.61M4.05M
Days Payables Outstanding-448.79308.1241.8970.6283.81217.12
Short-Term Debt000000248K
Deferred Revenue (Current)00730K1.38M2.07M1.49M1.54M
Other Current Liabilities107K1.79M700K2.2M2.91M473K5.89M
Current Ratio15.63x16.60x12.55x14.62x10.14x6.15x4.34x
Quick Ratio15.63x16.18x12.28x14.09x9.39x5.48x3.73x
Cash Conversion Cycle-580.55439.75411.37448.92455.5338.4
Total Non-Current Liabilities0178K510K1.53M1.03M1.13M2.52M
Long-Term Debt0178K00000
Capital Lease Obligations00000066K
Deferred Tax Liabilities0000000
Other Non-Current Liabilities010064K78K1.73M
Total Liabilities1.79M4.29M16.25M10.33M9.8M9.86M14.26M
Total Debt0178K00185K269K0
Net Debt-26.44M-62.5M-188.5M-118.24M-75M-37.38M-35.09M
Debt / Equity-0.00x--0.00x0.01x-
Debt / EBITDA-------
Net Debt / EBITDA-------
Interest Coverage-------
Total Equity
28.78M▲ 0%
67.23M▲ 133.6%
186.23M▲ 177.0%
123.72M▼ 33.6%
84.4M▼ 31.8%
49.04M▼ 41.9%
41.01M▼ 16.4%
Equity Growth %-133.59%176.99%-33.56%-31.78%-41.89%-16.38%
Book Value per Share6.222.672.651.761.180.680.44
Total Shareholders' Equity28.78M67.23M186.23M123.72M84.4M49.04M41.01M
Common Stock007K7K7K7K10K
Retained Earnings-48.04M-71.47M-136.32M-209.48M-253.72M-294.44M-330.02M
Treasury Stock0000000
Accumulated OCI0000000
Minority Interest0000000

HYPR Cash Flow Statement

Hyperfine, Inc. (HYPR) cash flow — operating, investing & free cash flow history

Line itemDec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25
Cash from Operations-18.37M-21.52M-47.18M-72.34M-41.81M-38.77M-27.95M
Operating CF Margin %--7321.43%-3153.88%-1061.62%-378.98%-300.75%-206.06%
Operating CF Growth %--17.16%-119.2%-53.32%42.2%7.28%27.91%
Net Income-19.41M-23.43M-64.85M-73.16M-44.24M-40.72M-35.57M
Depreciation & Amortization141K289K726K1.01M1.05M1.01M1.09M
Stock-Based Compensation896K1.12M6.9M10.65M4.74M4.36M2.8M
Deferred Taxes0000000
Other Non-Cash Items4K169K1.07M91K249K204K-677K
Working Capital Changes2K327K8.97M-10.93M-3.62M-3.62M4.41M
Change in Receivables309K-956K981K-1.55M-1.57M-2.77M1.78M
Change in Inventory-651K-1.93M-2.67M-312K-2.21M562K-1.48M
Change in Payables467K-377K1.44M-1.57M533K382K2.43M
Cash from Investing-244K-1.57M-2.71M-585K-804K-383K-1.19M
Capital Expenditures-244K-1.57M-2.71M-585K-804K-383K-1.19M
CapEx % of Revenue-533.33%181.22%8.59%7.29%2.97%8.74%
Acquisitions0000000
Investments-------
Other Investing0000000
Cash from Financing4.74M60.94M176.77M7K174K1.02M27.5M
Debt Issued (Net)-1M178K-178K0000
Equity Issued (Net)01000K1000K7K174K848K1000K
Dividends Paid0000000
Share Repurchases0000000
Other Financing5.74M991K146.48M00171K0
Net Change in Cash
-13.88M▲ 0%
37.84M▲ 372.7%
126.87M▲ 235.2%
-72.92M▼ 157.5%
-42.44M▲ 41.8%
-38.13M▲ 10.2%
-1.63M▲ 95.7%
Free Cash Flow
-18.62M▲ 0%
-23.09M▼ 24.0%
-49.89M▼ 116.1%
-72.92M▼ 46.2%
-42.61M▲ 41.6%
-39.15M▲ 8.1%
-29.13M▲ 25.6%
FCF Margin %--7854.76%-3335.09%-1070.21%-386.27%-303.72%-214.8%
FCF Growth %--24.05%-116.05%-46.16%41.57%8.13%25.59%
FCF per Share-4.03-0.92-0.71-1.04-0.60-0.54-0.31
FCF Conversion (FCF/Net Income)0.98x0.92x0.73x0.99x0.95x0.95x0.79x
Interest Paid06K00000
Taxes Paid0000000

HYPR Key Ratios

Hyperfine, Inc. (HYPR) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric2019202020212022202320242025
Return on Equity (ROE)-65.27%-48.65%-51.16%-47.21%-42.51%-61.03%-79.01%
Return on Invested Capital (ROIC)--498.04%-3950.55%-3454.21%-485.03%-307.79%-316.35%
Gross Margin--162.24%-78.01%13.31%43.12%45.7%49.79%
Net Margin--7944.56%-4333.76%-1073.73%-401%-315.9%-262.29%
Debt / Equity-0.00x--0.00x0.01x-
FCF Conversion0.98x0.92x0.73x0.99x0.95x0.95x0.79x
Revenue Growth--408.84%355.48%61.9%16.84%5.22%

HYPR SEC Filings & Documents

Hyperfine, Inc. (HYPR) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Mar 18, 2026·SEC

Material company update

Mar 18, 2026·SEC

Material company update

Jan 12, 2026·SEC

10-K Annual Reports

4
FY 2026

Mar 18, 2026·SEC

FY 2025

Mar 17, 2025·SEC

FY 2024

Mar 22, 2024·SEC

10-Q Quarterly Reports

6
FY 2025

Nov 13, 2025·SEC

FY 2025

Aug 13, 2025·SEC

FY 2025

May 13, 2025·SEC

HYPR Frequently Asked Questions

Hyperfine, Inc. (HYPR) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Hyperfine, Inc. (HYPR) reported $13.6M in revenue for fiscal year 2025.

Hyperfine, Inc. (HYPR) grew revenue by 5.2% over the past year. This is steady growth.

Hyperfine, Inc. (HYPR) reported a net loss of $35.6M for fiscal year 2025.

Dividend & Returns

Hyperfine, Inc. (HYPR) has a return on equity (ROE) of -79.0%. Negative ROE indicates the company is unprofitable.

Hyperfine, Inc. (HYPR) had negative free cash flow of $29.1M in fiscal year 2025, likely due to heavy capital investments.

Explore More HYPR

Hyperfine, Inc. (HYPR) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.